Emergent BioSolutions Inc.EBSNYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank0
3Y CAGR-34.4%
5Y CAGR-25.9%
Year-over-Year Change
Research and development spending
3Y CAGR
-34.4%/yr
vs +7.2%/yr prior
5Y CAGR
-25.9%/yr
Recent deceleration
Acceleration
-41.5pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
5 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $53.20M | -24.8% |
| 2024 | $70.70M | -36.5% |
| 2023 | $111.40M | -40.8% |
| 2022 | $188.30M | -19.9% |
| 2021 | $235.20M | -1.1% |
| 2020 | $237.90M | +5.2% |
| 2019 | $226.20M | +58.4% |
| 2018 | $142.80M | +46.6% |
| 2017 | $97.40M | -8.9% |
| 2016 | $106.90M | - |